Crossmark

Low-value approvals and high prices might incentivize ineffective drug development

Crossref DOI link: https://doi.org/10.1038/s41571-018-0030-2

Published Online: 2018-05-15

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Prasad, Vinay

McCabe, Christopher

Mailankody, Sham
License Information

Text and Data Mining valid from 2018-05-15
More Information

Article History

First Online: 15 May 2018

Competing interests

: The authors declare no competing interests.